Vladimir Coric
Chief Executive Officer bij BIOHAVEN LTD.
Vermogen: 172 M $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
John Childs | M | 81 |
Veradermics, Inc.
Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice.
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | 10 jaar |
Gregory Bailey | M | 68 | 10 jaar | |
Julia Gregory | F | 71 | 7 jaar | |
Christopher Boerner | M | 53 | 9 jaar | |
George Clark | M | - | 5 jaar | |
Kimberly Gentile | F | 56 | 23 jaar | |
Irina Antonijevic | M | 59 | 2 jaar | |
Clifford Bechtold | M | - | 10 jaar | |
Kollol Pal | M | - |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | - |
Michael Heffernan | M | 59 | 4 jaar | |
Phil Holzer | M | 48 | 11 jaar | |
Mark Foley | M | 58 | 7 jaar | |
Robert Hugin | M | 69 | 4 jaar | |
Matthew Buten | M | 62 | 3 jaar | |
Douglas G. Gray | M | - | - | |
Kishan Mehta | M | 38 | 3 jaar | |
James Engelhart | M | 60 |
Our Lady of Mercy Academy
| 6 jaar |
Douglas Taylor Falk | M | - |
Vita Therapeutics, Inc.
Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | 5 jaar |
Jordan Leef | M | - |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | - |
Louis Schmukler | M | - | 13 jaar | |
Carey Kolaja | F | 51 | 3 jaar | |
Gerald Storch | M | 67 | 12 jaar | |
Christian Nolet | M | 67 | 5 jaar | |
Tobin Schilke | M | 49 | 6 jaar | |
Melissa Beiner | M | - | 7 jaar | |
Dwight Moxie | M | 48 | 4 jaar | |
Timothy Durso | M | - |
Veradermics, Inc.
Veradermics, Inc. Pharmaceuticals: MajorHealth Technology VeraDermics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing drugs for immunologic and dermatologic diseases. The company is based in San Antonio, TX. The company has a portfolio of five product candidates that target common skin conditions such as warts, hair loss, and eczema. Founded by dermatologists, VeraDermics leverages its clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. | - |
Olivia Ware | F | 67 | 3 jaar | |
Brian Lestini | M | - |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | 3 jaar |
David Saunders | M | - | 4 jaar | |
Irfan Qureshi | M | - | - | |
Megan M. Dow | M | - | 4 jaar | |
Angus Russell | M | 68 | 13 jaar | |
Julian Gangolli | M | 66 | 8 jaar | |
Paloma Moraleda | F | - | 2 jaar | |
Gastón Ortega | M | - | 2 jaar | |
Jill Beraud | F | 63 | 5 jaar | |
Jennifer Porcelli | F | - | 2 jaar | |
Deborah Jagielow | F | - |
Yale School of Medicine
| - |
Warren Volles | M | - | - | |
Erica Jordan | F | - | - | |
Lajos Pusztai | M | - |
Yale School of Medicine
| - |
Rita Berkson | F | - |
Yale School of Medicine
| - |
Patricia Zandy | F | - |
Yale School of Medicine
| - |
Marcella Nunez-Smith | F | - |
Yale School of Medicine
| - |
Pasko Rakic | M | - |
Yale School of Medicine
| - |
Nick Kozauer | M | - | 1 jaar | |
Daniel Petrylak | M | - |
Yale School of Medicine
| - |
Mark Nuttall | M | - |
Vita Therapeutics, Inc.
Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | - |
William Perhacs | M | - | 17 jaar | |
Daniel DiCapua | M | - |
Yale School of Medicine
| - |
Chris Barrett | M | - | - | |
Zack Newman | M | - | 11 jaar | |
Shuai Li | M | - | 7 jaar | |
Lisa Stocking | F | - | - | |
Peter Cresswell | M | - |
Yale School of Medicine
| - |
James Rothman | M | 74 |
Yale School of Medicine
| - |
Kathleen E. Walsh | F | 68 |
Yale School of Medicine
| - |
Howard L. Haronian | M | 63 |
Yale School of Medicine
| 30 jaar |
Robert Alpern | M | 73 |
Yale School of Medicine
| 20 jaar |
Biren Amin | M | 51 |
Pyramid Biosciences, Inc.
Pyramid Biosciences, Inc. BiotechnologyHealth Technology Pyramid Biosciences, Inc. operates as a biotechnology company. It develops new therapies focused on the modulation of cell surface. The company was founded by Kollol Pal and Jordan Leef and is headquartered in Waltham, MA. | 2 jaar |
Arjun Kalyanpur | M | 59 |
Yale School of Medicine
| - |
Harvey J. Berger | M | 74 |
Yale School of Medicine
| - |
Michael William Cleman | M | - |
Yale School of Medicine
| - |
David Hollander | M | 50 | 2 jaar | |
Jon Blaskovich | M | - | - | |
Karl Insogna | M | - |
Yale School of Medicine
| - |
Conor Gallagher | M | - | 6 jaar | |
Caroline Dircks | M | - | 4 jaar | |
Joseph P. Schlessinger | M | 79 |
Yale School of Medicine
| 23 jaar |
Michael S. Kaminer | M | 62 |
Yale School of Medicine
| - |
Raymond Sanchez | M | 63 |
Yale School of Medicine
| - |
Maryellen McQuade | F | - | - | |
Jessica Serra | F | - | - | |
Azita Nejad | F | - | 10 jaar | |
James Peyer | M | - |
Vita Therapeutics, Inc.
Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
James Cornelius | M | 81 | 10 jaar | |
Thomas Lynch | M | 63 |
Yale School of Medicine
| 10 jaar |
Dustin Sjuts | M | 45 | 6 jaar | |
Elyse Stock | M | 66 | 5 jaar | |
Robert Berman | M | 61 | 10 jaar | |
Declan Doogan | M | 72 | 8 jaar | |
John E. Celentano | M | 64 | 31 jaar | |
Michael Grobstein | M | 81 | 13 jaar | |
Alan J. Lacy | M | 70 | 12 jaar | |
Leif Valdemar Johansson | M | 73 | 13 jaar | |
Eric Aguiar | M | 62 | 4 jaar | |
Charles Sigal | M | 72 | 16 jaar | |
Brian Daniels | M | 65 | 14 jaar | |
Béatrice J. Cazala | F | 67 | 32 jaar | |
Philip Vickers | M | 64 | 8 jaar | |
Robert Williams | M | 75 | 7 jaar | |
Robert Repella | M | 65 | 2 jaar | |
Senthil Sundaram | M | 46 | - | |
Louis J. Freeh | M | 74 | 8 jaar | |
Charles Conway | M | 62 | 5 jaar | |
Anthony Hooper | M | 69 | 15 jaar | |
St John McGrath | M | - | 9 jaar | |
Togo Dennis West | M | 81 | 10 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 99 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Vladimir Coric
- Persoonlijk netwerk